SUBSCRIBE
SUBSCRIBE
News   Drug Development

Merck KGaA on Cancer Vaccines: We’re Not Crazy, Just Convinced

July 14, 2009 | 
1 min read
Bookmark and Share

BNET -- Merck KGaA claims they aren’t crazy for initiating a Phase III breast cancer trial with the therapeutic cancer vaccine Stimuvax — they’re just completely convinced the darn thing is going to work.
Clinical research Phase III
MORE ON THIS TOPIC
Balloon and missed bow spears arround . Target audience and marketing concept . This is a 3d render illustration .
Infectious disease
Insmed Delivers ‘Rare Disappointment’ as Brinsupri Flops in Mid-Stage Rhinosinusitis Study
December 19, 2025
 · 
2 min read
 · 
Tristan Manalac
Man holds up his hand to signify a pause or stop
ADCs
Patient Deaths Put Merck, Daiichi Sankyo’s Antibody-Drug Conjugate on Hold
December 19, 2025
 · 
2 min read
 · 
Tristan Manalac
Cambridge, Massachusetts, USA - 30 July 2024. Takeda Pharmaceutical Company logo on office building.Biotech industry
Immunology and inflammation
Takeda’s $4B Nimbus Bet Pays Off With ‘Best-in-Class’ Phase III Plaque Psoriasis Data
December 19, 2025
 · 
2 min read
 · 
Tristan Manalac
Deals
Inside the 2026 Biotech Landscape: Innovation, Investment and Global Momentum
December 18, 2025
 · 
1 min read
 · 
BioSpace Insights